腹部外科手术对PAI-1水平的影响:系统性审查和元分析
相关实验视频
Updated: May 6, 2026
07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
23.5K
Tannaz Jamialahamdi1,2, Elaheh Mirhadi3, Wael Almahmeed4
1Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Obesity surgery
|September 2, 2024
概括
腹腔外科手术显著降低了等离子体激活剂抑制剂-1 (PAI-1) 的水平. 这种效应在不同类型的手术和随访时间之间是一致的,独立于BMI变化.
科学领域:
- 代谢手术 代谢手术
- 心血管疾病生物标志物 心血管疾病生物标志物
背景情况:
- 血原激活剂抑制剂-1 (PAI-1) 的升高与肥胖和心血管疾病有关.
- 减肥手术是一种有效的肥胖治疗方法,但其对PAI-1的影响需要全面分析.
研究的目的:
- 进行一项元分析,评估减肥手术对循环PAI-1水平的影响.
- 调查手术类型或随访时间是否会影响PAI-1的减少.
主要方法:
- 使用综合元分析 (CMA) V4软件对33项研究的元分析.
- 在减肥手术之前和之后,分析循环PAI-1水平.
- 按手术类型 (LSG,RYGB) 和随访时间 (<12个月,≥12个月) 的分层.
主要成果:
- 腹部外科手术导致循环PAI-1的显著下降 (p < 0.001).
- 对于腹腔镜袖子胃切除术 (LSG) 和Roux-en-Y胃绕道 (RYGB) 均观察到显著的PAI-1减少.
- 随着随访时间的推移,PAI-1水平显著变化,不管手术后的BMI变化如何.
结论:
- 腹腔外科手术有效降低循环PAI-1水平.
- 观察到的PAI-1降低独立于手术后的BMI变化.
- 结果在各种减肥手术和随访时间之间是一致的,突出显示了手术在调节PAI-1中的作用.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
572
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
572
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
445
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445